This post is sponsored by CED.
CED, the Southeast’s largest entrepreneurial support organization, will feature the Biopharma and Medtech Emerging Company Showcase, showcasing the most promising emerging companies in North Carolina, which will occur at the CED Life Science Conference on Feb. 15–16, 2012 at the Raleigh Convention Center.
“North Carolina has an abundance of emerging life science companies ready for immediate growth,” said Joan Siefert Rose, CED president. “The CED Life Science Conference is the premier forum for these companies and their executive teams to showcase their promising technologies and product pipelines. Investors will be delighted to meet these companies and participate in other investor programs throughout the Conference.”
Throughout the conference, top tier investors, executives, founders of emerging companies and big pharmaceutical companies will interact with each other through an innovative partnering system. These partnering sessions often yield potential investment and strategic alliances.
“Creating the financial opportunity for the biotech industry to innovate and grow is essential to fulfilling unmet needs in human and environmental health,” said Bill Slattery, Partner, Deerfield Management Company L.P. “This Conference is crucial in generating the investment interest from investors that will help bring these new therapies and products to the market.”
Slattery will be joined by Kris H. Jenner of T. Rowe Price, James Geraghty of Genzyme, Chris Hite of Citigroup, and Mark Levin of Third Rock Ventures, on the Financing Panel. The panel will focus on the latest trends in life science financing and maximizing value creation.
The CED Life Science Conference is presented in partnership with the North Carolina Biotechnology Center and North Carolina Biosciences Organization, and has grown exponentially since its inception in 1991. Each year, the Conference attracts more than 800 industry professionals and investors.
CED’s mission is to identify, enable and promote emerging growth companies and to accelerate the entrepreneurial culture of the Research Triangle and North Carolina.
About NC Biotechnology Center
The Biotechnology Center is a private, non-profit corporation supported by the N.C. General Assembly. Its mission is to provide long-term economic and societal benefits to North Carolina by supporting biotechnology research, business, education and strategic policy statewide.
NCBIO is dedicated to promoting the future growth and development of North Carolina’s bioscience industry. NCBIO advocates for state and federal public policies that encourage the growth of life science companies, support the development of a strong life science workforce, and promote research and technology transfer at universities and other institutions. The Organization also provides members opportunities to network, collaborate and save money. NCBIO’s ultimate goal is to help North Carolina’s bioscience community fulfill its extraordinary promise as a source of economic opportunity and improved quality of life for citizens of North Carolina and people around the world.